Celixir is a developer of regenerative medicines created to change the lives of patients in need. The company's medicines consists of iMP cells, platelet lysate and PML cells to treat patients with ischaemic heart disease, injured tendons near the surface of the skin and mild to moderate heart failure respectively, enabling medical researchersto discover breakthrough medicines that aim to change the standard of medical care for patients.

Biotechnology

Health Care

Celixir

Celixir's headquarters in Cardiff, United Kingdom

Description

People (1)

Jobs (0)

Other offices